Lack of Diligence. Company has or will obtain the expertise necessary to independently evaluate the Licensed Patent(s) and intends to promote the development of Licensed Products for the commercial market. Company acknowledges that any failure by Company to exercise Diligent Efforts to reasonably implement the Development Plan, as amended from time to time, or to make timely submission to UWMRF of any updated Development Plan, or the providing of any false information to UWMRF regarding Company’s development activities hereunder, shall be a breach of this Agreement subject to the requirements of Article 4.3 hereof.
Appears in 3 contracts
Samples: Patent License Agreement (RespireRx Pharmaceuticals Inc.), Patent License Agreement (RespireRx Pharmaceuticals Inc.), Patent License Agreement (RespireRx Pharmaceuticals Inc.)
Lack of Diligence. Company COMPANY has or will obtain the expertise necessary to independently evaluate the Licensed Patent(s) and intends to promote the development of Licensed Products for the commercial market. Company COMPANY acknowledges that any failure by Company COMPANY to exercise Diligent Efforts to reasonably implement the Development Plan, as amended from time to time, or to make timely submission to UWMRF of any updated Development Plan, or the providing of any false information to UWMRF regarding CompanyCOMPANY’s development activities hereunder, shall be a breach of this Agreement subject to the requirements of Article 4.3 hereof.
Appears in 1 contract
Samples: Patent License Agreement